Logo small

OnkoCafe Foundation and HematoKoalition: 2023 should be the year of lymphoma

MedExpress Team


Published April 19, 2023 10:18

OnkoCafe Foundation and HematoKoalition: 2023 should be the year of lymphoma - Header image
Fot. iStock/Getty Images
- In recent years, a number of new molecules have been introduced in hematooncology, which has greatly increased the possibilities for modern treatment of many blood cancers. In some areas, however, we are still waiting for urgent medical needs and access to new therapies to be met. We are talking about lymphomas, for example, and I would like 2023 to be the year of lymphomas," says Anna Kupiecka, CEO of the OnkoCafe-Nazem Better Foundation and leader of the HematoCoalition.

Lymphomas are the most common blood cancers with widely varying types and courses. Some lymphomas are very aggressive and, in the absence of treatment, can lead to the death of the patient in just a few weeks, while others can be lived with many times longer. Modern therapies have greatly improved the situation of patients with lymphomas, so that not only can the disease be controlled or function better, but sometimes they even offer a chance for a permanent cure. The time has come to take comprehensive care of the system of care for this group of patients.

In line with recent trends in oncology, we are increasingly reaching for the most effective forms of treatment in the early lines. This approach increases patients' chances of a longer life and a better quality of life. It also means a better chance of a permanent cure.

- For diffuse large B-cell lymphoma (DLBCL), one of the most aggressive and common non-Hodgkin's lymphomas, the best results come from firs...

Content locked

To gain access to the complete English section of the, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also